(RTTNews) - Teva Pharmaceutical Industries Ltd (TEVA) announced the UK Medicines & Healthcare Regulatory Agency has decided to grant a licence for Ongavia, a biosimilar to Lucentis (ranibizumab), an ...
Royalty Pharma and the US affiliate of Israel’s Teva Pharmaceutical Industries have announced a funding agreement of up to ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an ...
Generics are coming at Emergent’s opioid overdose drug Narcan. On the same day in December, Teva and Sandoz launched copycat versions of the successful nasal spray, suggesting Narcan’s reign of ...
Under the agreement, Closed Loop Medicine – a leading TechBio company – and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicine’s proprietary software as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback